Transcriptomics

Dataset Information

0

Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy [3A]


ABSTRACT: Metabolic disorder is emerging as a crucial contributor to the pathogenesis of diabetic vascular complications including diabetic retinopathy (DR), the leading cause of blindness in the working-age population. Yet, the underlying molecular mechanisms of how the disturbed metabolic homeostasis contribute to vascular dysfunction in DR remain elusive. O-GlcNAcylation modification act as a nutrient sensor particularly sensitive to ambient glucose. Here, we observed pronounced O-GlcNAc elevation in retina endothelial cells (ECs) of DR patients and mouse models. Endothelial-specific depletion or pharmacological inhibition of O-GlcNAc transferase efficiently mitigated vascular dysfunctions. Mechanistically, we found that YAP/TAZ, key effectors of the Hippo pathway, are O-GlcNAcylated in DR. We identified Thr383 as an O-GlcNAc site on YAP, which inhibits its phosphorylation at Ser397, leading to its stabilization and activation. Consequently, highly activated YAP/TAZ, promotes vascular dysfunction by inducing a pro-angiogenic and glucose metabolic transcriptional program. These findings emphasize the critical role of O-GlcNAc-Hippo axis in DR pathogenesis and suggest its unique potential as a therapeutic target.

ORGANISM(S): Homo sapiens

PROVIDER: GSE266071 | GEO | 2024/09/24

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-09-24 | GSE266072 | GEO
2022-02-01 | GSE195751 | GEO
2017-06-20 | E-MTAB-5395 | biostudies-arrayexpress
2014-07-18 | E-GEOD-45155 | biostudies-arrayexpress
2022-05-08 | PXD026872 | Pride
2013-12-31 | E-GEOD-49384 | biostudies-arrayexpress
2023-08-13 | GSE240233 | GEO
2024-07-25 | PXD044829 | Pride
2024-07-25 | PXD054192 | Pride
2017-06-13 | PXD005751 | Pride